Clinical trial

Different Safety Profile of Risperidone and Paliperidone Extended-release

NCT01284959

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE4

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2012-10-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

risperidoneDRUG · verified · RxNorm: risperidone

paliperidone ERDRUG

Sponsors & collaborators

Chonbuk National University Hospitallead sponsor

AstraZenecacollaborator

Janssen Korea, Ltd., Koreacollaborator

Korea Otsuka Pharmaceutical Co., Ltd.collaborator

Sanofi-Synthelabocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01284959 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.